Mayo Clinic Laboratory and pathology research: May 3

By Meghann Southwick • May 3, 2022

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Acute glomerulonephritis.

Glomerulonephritis is a heterogeneous group of disorders that present with a combination of haematuria, proteinuria, hypertension, and reduction in kidney function to a variable degree. In the last few years, substantial progress has been made in unravelling the underlying causes and pathogenetic mechanisms of glomerulonephritis and a causal approach to the classification of glomerulonephritis is now favoured over a pattern-based approach.

Read more.

Published to PubMed This Week

• Comparison of cosyntropin, vigabatrin, and combination therapy in new-onset infantile spasms in a prospective randomized trial.
  Journal of child neurology
• Lipochoristoma of the cerebellopontine angle.
  Otology and neurotology
• Bringing mass spectrometry into the care of patients with multiple myeloma.
  International journal of hematology
• Point of care CYP2C19 genotyping after percutaneous coronary intervention.
  The pharmacogenomics journal
• Commentary: Completion posterior quadrant disconnection after failed temporal lobectomy: 2-dimensional operative video.
  Operative neurosurgery
• Cutaneous manifestations of hospitalized COVID-19 patients in the VIRUS COVID-19 registry.
  International journal of dermatology
• Rhamnose is superior to mannitol as a monosaccharide in the dual sugar absorption test: A prospective randomized study in children with treatment-naïve celiac disease.
  Frontiers in pediatrics
• MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.
  Virchows Archiv: an international journal of pathology
• Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease-related lesions.
  Human pathology
• Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot.
  Virchows Archiv: an international journal of pathology

Meghann Southwick

Meghann Southwick is a marketing specialist for Mayo Clinic Laboratories. She has worked at Mayo Clinic since 2021.